SOUTH SAN FRANCISCO, CA, November 4, 2026 – Circle Pharma, Inc., a clinical-stage biopharmaceutical company pioneering next-generation targeted macrocycle therapeutics for cancer, today announced management will participate in two upcoming investor conferences in November: Stifel 2026 Healthcare Conference Presentation: Thursday, November 12, 2026, 1:30 p.m. ET Participants: David J. Earp, J.D., Ph.D., president and chief […] The post Circle Pharma Announces Participation in November Investor Conferences appeared first on Circle Pharma .